These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 15226088)

  • 1. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
    Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
    Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
    Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
    Daniel WC; Meidell RS; Hillis LD; Lange RA
    Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS; Li EK; Leung VY; Griffith JF; Benzie IF; Lim PL; Whitney B; Lee VW; Lee KK; Thomas GN; Tomlinson B
    J Rheumatol; 2005 Feb; 32(2):275-82. PubMed ID: 15693087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of molsidomine on fibrinolytic activity: a double-blind, randomized study].
    Darius H; Grodzinska L; Hafner G; Meyer J
    Z Kardiol; 1991; 80 Suppl 5():47-50. PubMed ID: 1776335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
    Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
    Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
    Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
    Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients.
    Bonfigli AR; Pieri C; Manfrini S; Testa I; Sirolla C; Ricciotti R; Marra M; Compagnucci P; Testa R
    Diabetes Nutr Metab; 2001 Apr; 14(2):71-7. PubMed ID: 11383676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation and fibrinolysis in ischemic heart disease].
    Sakamoto T; Ogawa H; Miyao Y; Yasue H
    Rinsho Byori; 1994 Jan; 42(1):39-44. PubMed ID: 8107282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].
    Pang BS; Wang C; Lu Y; Yang YH; Xing GH; Mao YL; Huang XX; Zhai ZG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3074-8. PubMed ID: 18261355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic activity in multiple myeloma.
    Yağci M; Sucak GT; Haznedar R
    Am J Hematol; 2003 Dec; 74(4):231-7. PubMed ID: 14635202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress effects fibrinolytic system in dialysis uraemic patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2006; 117(5):517-22. PubMed ID: 15964061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.
    Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K
    Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
    Tousoulis D; Bosinakou E; Kotsopoulou M; Antoniades C; Katsi V; Stefanadis C
    Int J Cardiol; 2006 Jan; 106(3):333-7. PubMed ID: 16337041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma lipoprotein(a) levels and fibrinolytic activity in patients with unstable angina.
    Okubo H; Yasue H; Ogawa H; Misumi I; Masuda T; Miyao Y; Sakamoto T
    Jpn Circ J; 1993 Oct; 57(10):947-54. PubMed ID: 7901435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of thioredoxin in patients with coronary spastic angina.
    Miyamoto S; Kawano H; Sakamoto T; Soejima H; Kajiwara I; Hokamaki J; Hirai N; Sugiyama S; Yoshimura M; Yasue H; Nakamura H; Yodoi J; Ogawa H
    Antioxid Redox Signal; 2004 Feb; 6(1):75-80. PubMed ID: 14713337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
    Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.